Workflow
化学制品
icon
Search documents
化学制品板块12月23日涨0.07%,多氟多领涨,主力资金净流入7.94亿元
证券之星消息,12月23日化学制品板块较上一交易日上涨0.07%,多氟多领涨。当日上证指数报收于 3919.98,上涨0.07%。深证成指报收于13368.99,上涨0.27%。化学制品板块个股涨跌见下表: 以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。 从资金流向上来看,当日化学制品板块主力资金净流入7.94亿元,游资资金净流出2368.84万元,散户资 金净流出7.7亿元。化学制品板块个股资金流向见下表: ...
道恩股份:为子公司提供最高额1亿元担保,累计担保8.61亿元
Xin Lang Cai Jing· 2025-12-23 08:57
道恩股份公告称,2025年度公司预计为子公司、孙公司提供总计不超13.23亿元的担保额度。2025年12 月23日,公司与华夏银行青岛分行签订《最高额保证合同》,为持股80%的子公司海尔新材料提供最高 额不超1亿元的担保,保证期间三年,方式为连带责任保证。海尔新材料2024年营收25.01亿元,净利润 7126.32万元,资产负债率79.50%。截至公告日,公司及子公司累计对外担保总额8.61亿元,占最近一 期经审计归属于上市公司股东净资产的27.58%,无逾期等不良担保情况。 ...
天赐材料(002709):电解液盈利乘势而起,固态材料执笔未来
Soochow Securities· 2025-12-23 08:13
Investment Rating - The report maintains a "Buy" rating for the company [1] Core Views - The company is a leading player in the electrolyte industry, with a stable market share of over 30% as of October 2025. The price of hexafluorophosphate is expected to rise, significantly benefiting the company's profitability. The company is also strategically positioning itself in the solid-state battery materials sector, which is anticipated to become a second growth curve [9][11] - The demand for lithium batteries is projected to grow by over 30% in 2026, driven by a surge in energy storage needs and increased vehicle battery capacities. The company is expected to benefit from this demand surge, with hexafluorophosphate prices anticipated to exceed expectations [9][31] - The company has a robust financial outlook, with net profits expected to rebound significantly in the coming years, driven by rising hexafluorophosphate prices and the company's strategic investments in solid-state materials [9][24] Summary by Sections Company Overview - The company has been deeply involved in the electrolyte business for over 20 years, establishing itself as a global leader. It has a strong foothold in the supply chains of major players like CATL and Tesla, and has expanded its international presence with subsidiaries in Singapore, the Netherlands, and Morocco [15][19] Financial Data - The company's revenue and profit are stabilizing, with a projected revenue of 15.66 billion yuan in 2025, representing a year-on-year growth of 25.13%. The net profit is expected to reach 1.22 billion yuan, a significant increase of 152.41% compared to the previous year [1][24] - The company's gross margin is expected to stabilize around 18% in 2025, with effective cost control measures in place [27] Industry Analysis - The electrolyte industry is at a supply-demand inflection point, with significant price elasticity for hexafluorophosphate. The company is expected to benefit from this price increase, with forecasts suggesting a rise in hexafluorophosphate prices to over 200,000 yuan per ton in 2026 [9][31] - The global demand for energy storage is projected to grow by 65% in 2026, with the company positioned to capitalize on this trend through its comprehensive product offerings [33][34] Solid-State Battery Development - The company is actively developing solid-state battery materials, focusing on lithium sulfide and solid electrolytes, which are expected to be key components in future battery technologies. This strategic move is aimed at creating a second growth curve for the company [9][11][17]
凯盛新材:暂不知晓PEKK产品是否间接被应用于液冷服务器系统领域中
Ge Long Hui· 2025-12-23 07:53
格隆汇12月23日丨凯盛新材(301069.SZ)在互动平台表示,公司的PEKK产品已被广泛应用于多个领域, 包括通用型材、喷涂、新能源汽车、军工航空航天等。同时,公司也在紧密跟踪电子信息(半导体)、 康复医疗器械、机器人等领域对于轻量化特种材料的发展动向并积极开拓国内外市场。公司暂不知晓 PEKK产品是否间接被应用于液冷服务器系统领域中。 ...
凯盛新材(301069.SZ):暂不知晓PEKK产品是否间接被应用于液冷服务器系统领域中
Ge Long Hui· 2025-12-23 07:52
格隆汇12月23日丨凯盛新材(301069.SZ)在互动平台表示,公司的PEKK产品已被广泛应用于多个领域, 包括通用型材、喷涂、新能源汽车、军工航空航天等。同时,公司也在紧密跟踪电子信息(半导体)、 康复医疗器械、机器人等领域对于轻量化特种材料的发展动向并积极开拓国内外市场。公司暂不知晓 PEKK产品是否间接被应用于液冷服务器系统领域中。 ...
午间公告:仲景食品发布西洋参新产品;联泓新科锂电添加剂VC装置成功投产
Group 1 - Company Zhongjing Food has recently launched new products in the health food sector, including concentrated American ginseng liquid and American ginseng tea, marking its strategic expansion into this market [1] - The new products are currently in the market introduction phase, and their future sales performance, market share, and impact on the company's financial results remain uncertain [1] Group 2 - Company Lianhong Xinke's subsidiary, Shandong Huayu Tongfang Electronic Materials Co., Ltd., has successfully put into operation a 4,000 tons/year lithium battery additive vinyl carbonate (VC) facility on December 22, 2025, producing qualified products [1] Group 3 - Company Nenghui Technology's convertible bonds have their last conversion day on December 23, 2025, after which unconverted bonds will be forcibly redeemed at a price of 100.73 yuan per bond, potentially leading to investment losses for investors [1] Group 4 - Xiamen Port Authority is set to have a review meeting on December 29, 2025, by the Shenzhen Stock Exchange's merger and acquisition review committee to assess the company's acquisition of a 70% stake in Xiamen Container Terminal Group Co., Ltd. and the issuance of shares to raise matching funds [1]
永太科技股价涨5.29%,中海基金旗下1只基金重仓,持有1.33万股浮盈赚取1.65万元
Xin Lang Cai Jing· 2025-12-23 03:36
Group 1 - The core point of the news is that Yongtai Technology's stock price increased by 5.29% to 24.69 CNY per share, with a trading volume of 1.145 billion CNY and a turnover rate of 5.89%, resulting in a total market capitalization of 22.841 billion CNY [1] - Yongtai Technology, established on October 11, 1999, and listed on December 22, 2009, is located in the chemical raw material pharmaceutical base in Zhejiang Province. The company specializes in the research, production, and sales of fluorine fine chemicals, specialty chemical raw materials, chemical preparations, and traditional Chinese medicine [1] - The revenue composition of Yongtai Technology includes lithium battery and other materials at 33.38%, trade at 30.87%, plant protection at 19.50%, and pharmaceuticals at 16.04%, with other segments contributing 0.21% [1] Group 2 - From the perspective of fund holdings, one fund under China Ocean Fund has a significant position in Yongtai Technology. The China Ocean Haiyi Mixed A Fund (013581) held 13,300 shares in the third quarter, accounting for 0.5% of the fund's net value, making it the fifth-largest holding [2] - The China Ocean Haiyi Mixed A Fund (013581) was established on November 16, 2021, with a latest scale of 20.8383 million CNY. Year-to-date, it has a return of 0.16%, ranking 7908 out of 8177 in its category; over the past year, it has incurred a loss of 0.69%, ranking 7912 out of 8146; since inception, it has a return of 0.21% [2]
盘前公告淘金:卓然股份子公司签40.33亿PBAT项目合同,华联控股拟12.35亿切入盐湖提锂
Jin Rong Jie· 2025-12-23 01:47
Investment Highlights - Zhuoran Co., Ltd. signed a total contract for a 4.033 billion yuan annual production of 1.2 million tons PBAT biodegradable polyester project, accounting for 142% of the company's audited revenue for 2024 [1][2] - Hualian Holdings plans to acquire 100% of Argentum for 1.235 billion yuan, entering the lithium extraction business from salt lakes [1][2] - Xusheng Group's actual controller has changed to the Guangzhou Municipal Government, and the stock has resumed trading [1] - Tianpu Co., Ltd. has a new actual controller, Yang Gongyifan, who, along with his concerted actors, controls 68.29% of the shares, and the stock has resumed trading [1] - Xiangyu Medical's brain-computer interface products have entered over 500 tier-three hospitals, with a target of over 700 by the Spring Festival [1] - Tongyu Communication's subsidiary Zhonghong Tongyu plans to increase capital and introduce investors to enhance its capital strength for satellite communication product R&D and operational expenses [1] - Lingyun Optical's wholly-owned subsidiary intends to act as a cornerstone investor in the IPO of Zhipu on the Hong Kong Stock Exchange [1] - Tainkang's wholly-owned subsidiary received a drug registration certificate for Finasteride and Tadalafil capsules, a product not yet approved by other companies in China [1] - Wantai Biological's bivalent human papillomavirus vaccine has been included in the 2025 National Immunization Program centralized procurement project [1] - Sanli Pharmaceutical plans to acquire the HXW2324 compound and related patents from Hainan University for developing new treatment candidates for Alzheimer's disease [1] - Haohan Depth has provided safety system support for L3 level autonomous driving in multiple regions [1] - Guangxun Technology's 1.6T optical module has achieved mass delivery capability [1] Capital Operations - Super Sonic Electronics plans to invest 1 billion yuan in upgrading and expanding high-performance HDI printed circuit board technology [2] - EVE Energy's headquarters for sodium energy and the Jin Yuan Robot AI Center project has commenced construction [2] - Lingyi Zhi Zao intends to acquire 35% of server thermal management company Liminda for 875 million yuan [3] - Nanya New Materials plans to raise no more than 900 million yuan for AI computing power-based high-end high-frequency high-speed copper-clad laminate R&D and industrialization projects [3] - Jinpan Technology plans to issue 1.672 billion yuan in convertible bonds for data center power module projects [3] - China Nuclear Construction's subsidiary introduced ICBC Investment to increase capital by 5 billion yuan for market-oriented debt-to-equity swaps to repay financial institution loans [3] - Yongding Co., Ltd.'s optical chip subsidiary plans to increase capital and introduce external investors such as Cambridge Technology [3] Performance Forecast - Sanhua Intelligent Control expects a net profit of 3.9 billion to 4.6 billion yuan in 2025, representing a year-on-year growth of 25% to 50% [4]
又一生物基尼龙企业IPO首发获批!
Sou Hu Cai Jing· 2025-12-23 00:59
Core Viewpoint - Changyu Group's IPO approval marks a significant milestone for the company and signals positive developments for the bio-based nylon industry chain [2][14]. Group 1: Company Overview - Changyu Group has received approval for its IPO application on the Shanghai Stock Exchange, with the meeting held on December 19, 2025 [2]. - The company was established in April 2019, with a registered capital of 366.875231 million yuan, and is controlled by Liu Qiyong and Liu Ce [5]. - The main products of the company include zirconium oxychloride, zirconium carbonate, zirconium oxide, nano-composite zirconium oxide, specialty nylon, long-chain dicarboxylic acids (bio-based), long-chain diols, and long-chain dimethyl esters [5]. Group 2: Investment Projects - The project for producing 10,000 tons of high-performance nylon elastomer products has a total investment of 248 million yuan, with 240 million yuan to be raised through the IPO, accounting for 34% of the total fundraising [3]. - The company has established R&D and production capabilities from long-chain dicarboxylic acids to downstream specialty nylon and modified products [5]. Group 3: Financial Performance - From 2022 to the first half of 2025, the company's revenue figures were 1.6694774 billion yuan, 1.6080036 billion yuan, 1.6376778 billion yuan, and 896286.1 million yuan, respectively [11]. - The net profit attributable to the parent company for the same period was 263.2768 million yuan, 195.4148 million yuan, 212.1245 million yuan, and 112.6974 million yuan [11]. - The gross profit margin for the main business was 28.35%, 23.27%, 23.83%, and 23.54% for the respective years [11]. Group 4: Product Development - The specialty nylon products have an annual polymerization capacity of 15,000 tons, covering over 50 grades, and are widely used in various industries such as machinery manufacturing, automotive, mobile phones, 3D printing, special clothing, and food packaging [7]. - The company is currently in the small-scale testing phase for bio-based transparent polyamide, aiming for a bio-based carbon content of over 45% [9][10]. Group 5: Market Position and Industry Impact - The successful IPO and capacity expansion plans of Changyu Group are expected to increase market demand for upstream raw material suppliers, particularly for long-chain dicarboxylic acids [15]. - The production of specialty nylon relies heavily on long-chain dicarboxylic acids, with key suppliers like Kasei Bio providing essential materials for the production of various polyamides [15].
锦鸡股份:产品价格受宏观经济环境、原材料价格况等多种因素影响
Group 1 - The company, Jinji Co., stated that product prices are influenced by various factors including macroeconomic environment, raw material prices, market supply and demand, and industry competition [1] - The company will make timely and moderate adjustments to pricing based on changes in the aforementioned factors and order conditions [1] - Detailed product pricing involves commercial secrets and is not convenient for regular updates on the official website [1]